Clinical, laboratory, and haemocoagulative data in diabetics (in relation to diabetic retinopathy: BDR = background DR; NPDR = non-proliferative DR; PDR = proliferative DR) and in healthy controls (n = mean(SD)
| No DR (n = 22) | BDR (n = 21) | NPDR (n = 15) | PDR (n = 9) | Controls (n = 50) | |
| Sex (M/F) | 9/13 | 5/15 | 2/5 | 6/12 | 19/31 |
| Age range (years) | 16–55 | 15–62 | 16–65 | 24–70 | 20–68 |
| Mean age (years) | 36.4 (10.5) | 41.2 (17.3) | 42.10 (12.3) | 43.6 (13.1) | 38.6 (12.2) |
| Duration of diabetes (years) | 11.4 (6.9) | 17.8 (5.7) | 18.0 (1.2) | 18.1 (7.2) | — |
| HbA1c (%) | 6.1 (1.0) | 6.2 (1.1) | 6.3 (1.2) | 6.6 (1.0) | — |
| Microalbuminuria (patients) | — | 2 | 5 | 9 | — |
| Macroalbuminuria (patients) | — | — | — | 9 | — |
| Total cholesterol (mg/dl) | 180.9 (31.0) | 187.5 (46.0) | 192.1 (31.1) | 204.2 (49.4) | 189.6 (22.7) |
| HDL cholesterol (mg/dl) | 51.4 (9.8) | 47.8 (6.7) | 47.2 (5.2) | 46.4 (8.4) | 50.4 (3.5) |
| Triglycerides (mg/dl) | 118.8 (52.6) | 131.5 (46.8) | 140.1 (31.3) | 165.2 (34.5) | 144.6 (28.2) |
| FVII:Ag (% standard) | 98.6 (33.1) | 108.8 (30.9) | 117.6 (22.8) | 131.6 (21.7) | 102.9 (29.8) |
| FVII:c (U/dl) | 79.7 (18.4) | 92.8 (16.9) | 105.3 (10.4) | 126.0 (34.3) | 88.6 (15.8) |
| F1+2 (μg/l) | 0.82 (0.46) | 1.08 (0.58) | 1.07 (0.43) | 1.41 (0.61) | 0.78 (0.24) |
-
↵PDR v No DR, PDRv BDR, PDR vcontrols: p <0.005; PDR v NPDR: p <0.05
-
No DR v controls: p >0.05 (not significant).
-
↵PDR v No DR, PDRv BDR, PDR vcontrols: p <0.0001; PDR v NPDR: p <0.05
-
No DR v controls: p >0.05 (not significant).
-
↵PDR v No DR, PDRv controls: p <0.005; PDRv BDR, PDR vNPDR: p <0.05
-
No DR v controls: p >0.05 (not significant).
